biotech news today glp-1 Lilly is now pharma's top revenue company. It just got FDA approval for an oral GLP-1, but Wall Street isn't celebrating This biotech is working on

After injecting Wegovy, remove the needle and dispose of it safely

Liraglutide (Saxenda) for weight management escalates weekly from 0.6 mg to a maintenance dose of 3 mg daily

Acknowledgments The authors thank the contributions of Asan Medical Library (University of Ulsan College of Medicine, Seoul, Republic of Korea) for providing search terms for the systematic review and Enago (www.enago.co.kr) for the English-language review

Orforglipron Name: Orforglipron Manufacturer: Eli Lilly Current stage: Expected to submit for regulatory approval by the end of 2025 Takeaway: Less effective than injectables for mean weight loss, but a daily pill could suit some patients better

They make eating less effortless

SGLT-2 inhibitors reduce mortality in lower-risk patients, although absolute benefits are smaller